[Clinical use of radioprotector amifostine (YM-08310)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D004999:Amifostine / Q000627:therapeutic use*; D002648:Child; D003967:Diarrhea / Q000517:prevention & control; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008223:Lymphoma / Q000532:radiotherapy*; D008875:Middle Aged; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000532:radiotherapy*
D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D004999:Amifostine